Anti-angiogenic effect of high-dose resveratrol in a swine model of metabolic syndrome

Surgery

Volumn 148, Issue 2, 2010, Pages 453-462

  Robich, Michael P ^a,b   Chu, Louis M ^b   Chaudray, Mirnal ^a   Nezafat, Reza ^a   Han, Yuchi ^a   Clements, Richard T ^b   Laham, Roger J ^a   Manning, Warren J ^a   Coady, Michael A ^c   Sellke, Frank W ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BROWN UNIVERSITY   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC PROTEIN; ANGIOSTATIN; CHOLESTEROL; GLUCOSE; LOW DENSITY LIPOPROTEIN; METALLOPROTEINASE; RESVERATROL; THROMBOSPONDIN; VASCULAR ENDOTHELIAL CADHERIN; ANGIOGENESIS INHIBITOR; CADHERIN; LEUKOCYTE ANTIGEN; STILBENE DERIVATIVE;

ANGIOCARDIOGRAPHY; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; BODY MASS; CAPILLARY DENSITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLUCOSE BLOOD LEVEL; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HYPERCHOLESTEROLEMIA; IMMUNOBLOTTING; METABOLIC SYNDROME X; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWINE; SYSTOLIC BLOOD PRESSURE; ANIMAL; CHOLESTEROL INTAKE; COLLATERAL CIRCULATION; MALE; METABOLISM; MINIPIG; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

ANGIOGENESIS INHIBITORS; ANGIOSTATINS; ANIMALS; ANTIGENS, CD; CADHERINS; CHOLESTEROL, DIETARY; COLLATERAL CIRCULATION; CORONARY ANGIOGRAPHY; DISEASE MODELS, ANIMAL; MAGNETIC RESONANCE IMAGING; MALE; METABOLIC SYNDROME X; MYOCARDIAL ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; STILBENES; SWINE; SWINE, MINIATURE;

EID: 77955295236     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2010.04.013     Document Type: Article

References (25)

1. P. Meier, S. Gloekler, R. Zbinden, S. Beckh, S.F. de Marchi, and S. Zbinden Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements Circulation 116 2007 975 983
2. M. Boodhwani, N.R. Sodha, R.J. Laham, and F.W. Sellke The future of therapeutic myocardial angiogenesis Shock 26 2006 332 341
3. N.R. Sodha, R.T. Clements, M. Boodhwani, S.H. Xu, R.J. Laham, and C. Bianchi Endostatin and angiostatin are increased in diabetic patients with coronary artery disease and associated with impaired coronary collateral formation Am J Physiol Heart Circ Physiol 296 2009 H428 H434
4. M.S. O'Reilly, T. Boehm, Y. Shing, N. Fukai, G. Vasios, and W.S. Lane Endostatin: an endogenous inhibitor of angiogenesis and tumor growth Cell 88 1997 277 285
5. M.S. O'Reilly, L. Holmgren, Y. Shing, C. Chen, R.A. Rosenthal, and M. Moses Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma Cell 79 1994 315 328
6. T. Matsunaga, W.M. Chilian, and K. March Angiostatin is negatively associated with coronary collateral growth in patients with coronary artery disease Am J Physiol Heart Circ Physiol 288 2005 H2042 H2046
7. M. Potente, L. Ghaeni, D. Baldessari, R. Mostoslavsky, L. Rossig, and F. Dequiedt SIRT1 controls endothelial angiogenic functions during vascular growth Genes Dev 21 2007 2644 2658
8. S.V. Penumathsa, S. Koneru, S.M. Samuel, G. Maulik, D. Bagchi, and S.F. Yet Strategic targets to induce neovascularization by resveratrol in hypercholesterolemic rat myocardium: role of caveolin-1, endothelial nitric oxide synthase, hemeoxygenase-1, and vascular endothelial growth factor Free Radic Biol Med 45 2008 1027 1034
9. T. Walle, F. Hsieh, M.H. DeLegge, J.E. Oatis Jr., and U.K. Walle High absorption but very low bioavailability of oral resveratrol in humans Drug Metab Dispos 32 2004 1377 1382
10. P.J. Elliott, and M. Jirousek Sirtuins: novel targets for metabolic disease Curr Opin Investig Drugs 9 2008 371 378
11. M. Boodhwani, P. Voisine, M. Ruel, N.R. Sodha, J. Feng, and S.H. Xu Comparison of vascular endothelial growth factor and fibroblast growth factor-2 in a swine model of endothelial dysfunction Eur J Cardiothorac Surg 33 2008 645 650
12. S. Ryf, K.V. Kissinger, M.A. Spiegel, P. Bornert, W.J. Manning, and P. Boesiger Spiral MR myocardial tagging Magn Reson Med 51 2004 237 242
13. I. Haber, D.N. Metaxas, and L. Axel Three-dimensional motion reconstruction and analysis of the right ventricle using tagged MRI Med Image Anal 4 2000 335 355
14. M. Cohen, and K.P. Rentrop Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study Circulation 74 1986 469 476
15. D. Vestweber, M. Winderlich, G. Cagna, and A.F. Nottebaum Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player Trends Cell Biol 19 2009 8 15
16. F. Breviario, L. Caveda, M. Corada, I. Martin-Padura, P. Navarro, and J. Golay Functional properties of human vascular endothelial cadherin (7B4/cadherin-5), an endothelium-specific cadherin Arterioscler Thromb Vasc Biol 15 1995 1229 1239
17. N. Rahimi, and A. Kazlauskas A role for cadherin-5 in regulation of vascular endothelial growth factor receptor 2 activity in endothelial cells Mol Biol Cell 10 1999 3401 3407
18. M.L. Wahl, D.J. Kenan, M. Gonzalez-Gronow, and S.V. Pizzo Angiostatin's molecular mechanism: aspects of specificity and regulation elucidated J Cell Biochem 96 2005 242 261
19. K. Brew, D. Dinakarpandian, and H. Nagase Tissue inhibitors of metalloproteinases: evolution, structure and function Biochim Biophys Acta 1477 2000 267 283
20. H. Sato, T. Takino, Y. Okada, J. Cao, A. Shinagawa, and E. Yamamoto A matrix metalloproteinase expressed on the surface of invasive tumour cells Nature 370 6484 1994 61 65
21. B.P. Eliceiri, and D.A. Cheresh Adhesion events in angiogenesis Curr Opin Cell Biol 13 2001 563 568
22. L.C. Armstrong, and P. Bornstein Thrombospondins 1 and 2 function as inhibitors of angiogenesis Matrix Biol 22 2003 63 71
23. N.R. Sodha, M. Boodhwani, R.T. Clements, S.H. Xu, K.R. Khabbaz, and F.W. Sellke Increased antiangiogenic protein expression in the skeletal muscle of diabetic swine and patients Arch Surg 143 2008 463 470
24. S.-H. Tseng, S.-M. Lin, J.-C. Chen, Y.-H. Su, H.-Y. Huang, and C.-K. Chen Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats Clin Cancer Res 10 2004 2190 2202
25. J. Dudley, S. Das, S. Mukherjee, and D.K. Das Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose J Nutr Biochem 20 2009 443 452